Skip to content

Clinical trials

Completed Gastrointestinal Stromal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Status: Completed Country / region: United States Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20014
20025
20034
20042
20054
20063
20076
20084
20093
20103
20114
20125
20135
20142
20154
20162
20172
20183
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)13
Novartis Pharmaceuticals11
Northwestern University4
Pfizer4
Blueprint Medicines Corporation3
Deciphera Pharmaceuticals, LLC3
M.D. Anderson Cancer Center3
Memorial Sloan Kettering Cancer Center3
Astex Pharmaceuticals, Inc.2
Dana-Farber Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors79
Stomach Neoplasms19
Sarcoma18
Pancreatic Neoplasms16
Colonic Neoplasms15
Neoplasms12
Rectal Neoplasms12
Breast Neoplasms11
Carcinoma, Non-Small-Cell Lung11
Esophageal Neoplasms11

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.